TB-500 10 mg
Educational recon guide for a 10 mg TB-500 research vial and multi-mg loading/maintenance unit mapping. Research use only.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
10 mg
Your BAC water
2 mL
Concentration
5.00 mg/mL
Per unit
~50.0 mcg
Frequency
Loading often 2× weekly multi-mg, then lower weekly maintenance in secondary write-ups
Route
Subcutaneous (sometimes near injury site in community discussions)
Live reconstitution calculator
Defaults match this guide (10 mg + 2 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
Quick-select common research doses (includes 2.5 / 7.5 for dual-agonist ladders) or type any mg / mcg value.
Quick select (mg) — switch units or type any value
Suggested: 50-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
40 units
Volume
0.400 mL
Doses per vial
5
Syringes needed
1
Barrel
50-unit
Fits one syringe?
Yes
50-unit · 0.5 mL
Filled to 40 u
Fill one 50-unit U-100 syringe to about 40 units (0.400 mL).
Weekly research phases
Units and volumes recompute from your Step 1 concentration (2 mL BAC → 5.00 mg/mL · 50.0 mcg/unit).
Standard titration
Secondary educational tables commonly load roughly ~2–5 mg per injection, 2× weekly for several weeks (≈4–10 mg/week), then reduce to lower weekly or less-frequent maintenance. Not an FDA-approved drug.
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Load · 2 mg per injection | 2 mg2,000 mcg | 40 u | 0.40 mLCommon lower load amount (often 2×/week) |
| Load · 2.5 mg per injection | 2.50 mg2,500 mcg | 50 u | 0.50 mLCommon mid load amount |
| Load · 5 mg per injection | 5 mg5,000 mcg | 100 u | 1.00 mLUpper common load amount |
Advanced / higher-end
Faster escalation discussed in research communities — not a clinical recommendation
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Maintenance illustration · 2 mg weekly | 2 mg2,000 mcg | 40 u | 0.40 mLLower weekly maintenance-style amount after load |
Supplies planner
Using the guide’s phase ladder (2 mg → 2.5 mg → 5 mg weekly (phase ladder)) over a 12-week schedule. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
2 mL · 5.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
12-week schedule
TB-500 10 mg vials
4 vials
~38 mg mg total peptide over this 12-week schedule at 2 mg → 2.5 mg → 5 mg weekly (phase ladder). Each vial holds 10 mg.
Bacteriostatic water
3 × 3 mL or 1 × 10 mL
2 mL BAC per vial × 4 vials = 8.0 mL total. Buy as 3× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
12+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~32 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 10 mg TB-500 vial and bacteriostatic water to reach room temperature.
- Draw 2.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "5.0 mg/mL").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·Often discussed with BPC-157 (see blend guides).
- ·Research use only.
Research context & considerations
TB-500 is a synthetic fragment related to thymosin β4 research on cell migration and tissue repair. Evidence is largely preclinical/anecdotal relative to approved medicines.
- ·Theoretical angiogenesis/cancer-growth caution discussions exist for the class.
- ·Not FDA-approved.
- ·Pregnancy out of scope.
Catalog match
TB500 (BT10)
10mg x 10 vials · from $40